ABIO – arca biopharma, inc. (US:NASDAQ)
Stock Stats
News
9/3
11:04 pm
abio
Neutral
ARCA biopharma, Inc. (NASDAQ: ABIO) was upgraded by analysts at StockNews.com to a "sell" rating.
9/2
09:23 am
abio
Neutral
Upcoming Stock Splits This Week (September 2 to September 6) – Stay Invested [Yahoo! Finance]
8/29
04:54 pm
abio
Medium
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split [Yahoo! Finance]
8/29
04:50 pm
abio
Low
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
8/26
07:30 pm
abio
Medium
ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
8/30
05:58 pm
abio
Low
Form 4 ARCA biopharma, Inc. For: Aug 29 Filed by: Ma-Weaver Jacob
8/27
10:52 am
abio
Medium
Form SEC STAFF LETTER ARCA biopharma, Inc.
8/27
10:52 am
abio
Medium
Form SEC STAFF LETTER ARCA biopharma, Inc.
8/27
06:09 am
abio
Low
Form 425 ARCA biopharma, Inc. Filed by: ARCA biopharma, Inc.
8/27
06:05 am
abio
Low
Form 8-K ARCA biopharma, Inc. For: Aug 26
Show more
Top News Gainers
9/11 Arca Biopharma Announces Gencaro Atrial Fibrillation Clinical Data Selected for Presentation at HFSA 2019 Scientific Meeting 8.5%
5/17 Form CT ORDER ARCA biopharma, Inc. 3.5%
11/6 Q3/2019 9/30/2019 EPS -0.760 ZacksConsensus N/A ActVsEst N/A - N/A 3.0%
5/8 Form 10-Q ARCA biopharma, Inc. For: Mar 31 2.0%
Top News Decliners
2/26 Form S-1 ARCA biopharma, Inc. -21.2%
5/9 Form 8-K ARCA biopharma, Inc. For: May 09 -11.9%
5/13 ARCA biopharma Announces Submission of Patent Application to U.S. Patent and Trademark Office Covering Treatment of Atrial Fibrillation in Patients With Heart Failure -10.0%
5/14 Arca Biopharma Inc (NASDAQ: ABIO) was given a new $17.00 price target on by analysts at Ascendiant Capital Markets. They now have a "buy" rating on the stock. -7.3%
8/1 Form 10-Q ARCA biopharma, Inc. For: Jun 30 -4.7%
3/4 Form 8-K ARCA biopharma, Inc. For: Mar 03 -4.2%
5/20 Form 8-K ARCA biopharma, Inc. For: May 20 -3.9%
2/13 Form SC 13G/A ARCA biopharma, Inc. Filed by: RENAISSANCE TECHNOLOGIES LLC -3.9%
10/25 Form DEFA14A ARCA biopharma, Inc. -3.6%
2/18 Form 10-K ARCA biopharma, Inc. For: Dec 31 -2.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3